Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page's revision metadata rather than changes to the study content.SummaryDifference0.0%

- Check16 days agoChange DetectedA new line under Other Study ID Numbers adds 2017 (U.S. NIH Grant/Contract) as an identifier for the study. This links the trial to NIH funding and clarifies the funding source in the record.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This is a minor version update reflected in the page's revision history.SummaryDifference0.0%

- Check52 days agoChange DetectedA new revision number v3.6.4 has been added to the page. The previous revision v3.6.3 has been removed.SummaryDifference0.0%

- Check74 days agoChange DetectedDifference0.0%

- Check88 days agoChange DetectedNew sections and labels were added to the page’s help/navigation area, including No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment heading. The revision tag was updated to Revision: v3.6.0, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.